BridgeBio Pharma, Inc. (BBIO)
Pharmaceutical Preparations
Latest Price
$80.09
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
90.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.21M | $1.05B | 7.26% | -341.8K | 2026-03-31 |
| Kohlberg Kravis Roberts & Co. L.P. | 13.26M | $984.0M | 6.78% | -- | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 13.18M | $978.0M | 6.73% | +2.18M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.08M | $600.0M | 4.13% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.76M | $576.0M | 3.96% | -- | 2026-03-31 |
| UBS Group AG | 5.89M | $437.0M | 3.01% | +151.2K | 2026-03-31 |
| Aisling Capital Management LP | 5.09M | $377.0M | 2.60% | -- | 2026-03-31 |
| JANE STREET GROUP, LLC | 4.94M | $366.0M | 2.52% | +1.04M | 2026-03-31 |
| STATE STREET CORP | 4.93M | $366.0M | 2.52% | -28.5K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.92M | $371.0M | 2.51% | +505.5K | 2026-03-31 |